CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

Multiple myeloma (MM) is a plasma cell neoplasm that commonly expresses CD38. Daratumumab (DARA), a human monoclonal antibody targeting CD38, has significantly improved the outcome of patients with relapsed or refractory MM, but the response is transient in most cases. Putative mechanisms of subopti...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood
Main Authors: Naeimi Kararoudi, Meisam, Nagai, Yuya, Elmas, Ezgi, de Souza Fernandes Pereira, Marcelo, Ali, Syed Abbas, Imus, Philip Hollingsworth, Wethington, Darren, Borrello, Ivan Marques, Lee, Dean Anthony, Ghiaur, Gabriel
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2020
Fag:
Immunobiology and Immunotherapy
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685207/
https://ncbi.nlm.nih.gov/pubmed/32603414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020006200
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker